AIMEE GUIDRY: Open Payments
NPI 1679673412 · HENDERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 17 payments from 11 companies in 2025. Trend: 2023 $298 · 2024 $204 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Novo Nordisk Inc | 2 | $30 |
| Abbott Laboratories | 1 | $26 |
| Corium, LLC | 2 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: TRINTELLIX, VOQUEZNA, Auvelity, FREESTYLE LIBRE 3, Azstarys, MOUNJARO, LEQVIO, ZEPBOUND.
Industry payments across LA — which companies pay providers there.
